MSFT 416.9992 0.2113% AAPL 231.83 0.0216% NVDA 138.895 2.3394% GOOGL 163.53 -0.9869% GOOG 165.1 -0.9836% AMZN 187.78 0.4762% META 578.1245 0.2314% AVGO 183.5976 3.8331% TSLA 220.4371 -0.4034% TSM 207.9713 10.9299% LLY 917.515 -0.5652% V 289.845 0.8086% JPM 224.705 0.4762% UNH 568.2 -0.5496% NVO 118.43 0.3389% WMT 80.845 -0.4617% LVMUY 131.3 0.6439% XOM 120.36 -0.2486% LVMHF 659.0 1.0345% MA 513.11 -0.1867%
Last update at 2024-10-15T23:00:00Z
Shareholders in Oceania Healthcare (NZSE:OCA) are in the red if they invested three years ago
Sat 16 Dec 23, 09:00 PMDoes This Valuation Of Oceania Healthcare Limited (NZSE:OCA) Imply Investors Are Overpaying?
Thu 14 Sep 23, 01:26 AMShareholders in Oceania Healthcare (NZSE:OCA) are in the red if they invested five years ago
Sun 09 Jul 23, 08:30 PMOceania Healthcare's (NZSE:OCA) Dividend Is Being Reduced To NZ$0.013
Fri 26 May 23, 07:38 PMOceania Healthcare Limited (NZSE:OCA) Shares Could Be 21% Below Their Intrinsic Value Estimate
Thu 06 Apr 23, 11:49 PMInvestors in Oceania Healthcare (NZSE:OCA) have unfortunately lost 32% over the last three years
Sat 07 Jan 23, 08:00 PMOceania Healthcare (NZSE:OCA) Might Be Having Difficulty Using Its Capital Effectively
Sat 17 Dec 22, 09:32 PMBreakdown | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 | 2019-05-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 | 2019-05-31 |
Income before tax | 12.00M | 56.25M | 75.14M | 31.80M | 75.88M |
Minority interest | - | - | - | - | - |
Net income | 15.45M | 61.13M | 85.53M | 45.37M | 76.97M |
Selling general administrative | 164.64M | 158.94M | 115.69M | 127.33M | 122.36M |
Selling and marketing expenses | - | - | - | - | - |
Gross profit | 247.18M | 231.14M | - | 186.98M | 180.05M |
Reconciled depreciation | 17.92M | 18.62M | - | 14.49M | 9.54M |
Ebit | 35.44M | 70.39M | -4.01280M | 49.98M | 77.58M |
Ebitda | 53.36M | 89.01M | - | 59.52M | 86.42M |
Depreciation and amortization | 17.92M | 18.62M | - | 9.54M | 8.84M |
Non operating income net other | - | - | - | - | - |
Operating income | 35.44M | 70.39M | 3.67M | -20.29800M | 2.38M |
Other operating expenses | 247.62M | 236.72M | 56.91M | 213.94M | 184.60M |
Interest expense | 13.87M | 8.85M | 0.00000M | 3.00M | 2.94M |
Tax provision | -3.44800M | -4.87900M | -10.39600M | -14.66600M | -13.57600M |
Interest income | 1.76M | 0.08M | 73.68M | 28.92M | 43.33M |
Net interest income | -12.55600M | -9.30300M | - | -5.10600M | -2.85200M |
Extraordinary items | - | - | - | - | - |
Non recurring | - | - | - | - | - |
Other items | - | - | - | - | - |
Income tax expense | -3.44800M | -4.87900M | -12.47520M | -13.57600M | -1.09600M |
Total revenue | 247.18M | 231.14M | 175.42M | 186.98M | 180.05M |
Total operating expenses | 247.62M | 236.72M | - | 184.60M | 151.43M |
Cost of revenue | - | - | - | - | 123.75M |
Total other income expense net | -23.43900M | -14.14100M | - | 32.91M | 50.03M |
Discontinued operations | - | - | - | - | - |
Net income from continuing ops | 15.45M | 61.13M | - | -13.64200M | 45.37M |
Net income applicable to common shares | 15.45M | 61.13M | 102.82M | -13.64200M | 45.37M |
Preferred stock and other adjustments | - | - | - | - | - |
Breakdown | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2024-05-31 | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 |
Total assets | 2782.35M | 2544.94M | 2197.69M | 1883.73M | 1548.70M |
Intangible assets | 2.78M | 3.55M | 3.67M | 5.23M | 4.26M |
Earning assets | - | - | - | - | - |
Other current assets | 44.26M | 101.65M | 6.61M | 2.00M | 1.40M |
Total liab | 1755.89M | 1582.68M | 1248.85M | 1048.53M | 953.48M |
Total stockholder equity | 1026.46M | 962.26M | 948.84M | 835.20M | 595.21M |
Deferred long term liab | - | - | - | - | - |
Other current liab | 1004.77M | 969.17M | 814.70M | 623.78M | 535.37M |
Common stock | 715.96M | 713.37M | 705.29M | 675.62M | 588.39M |
Capital stock | 715.96M | 713.37M | 705.29M | - | 588.39M |
Retained earnings | -34.26400M | -68.49600M | -54.73500M | -86.98300M | -155.90700M |
Other liab | - | 66.87M | 65.07M | 60.12M | 51.00M |
Good will | 2.88M | 3.17M | 4.93M | 5.34M | 6.57M |
Other assets | - | 1597.72M | 1378.55M | 1099.80M | 947.80M |
Cash | 7.49M | 7.44M | 9.74M | 79.91M | 17.62M |
Cash and equivalents | - | - | - | - | - |
Total current liabilities | 1104.17M | 1024.29M | 858.81M | 647.22M | 615.03M |
Current deferred revenue | 47.34M | 45.33M | 42.07M | - | 34.34M |
Net debt | 644.24M | 550.95M | 380.29M | - | 320.83M |
Short term debt | 37.08M | - | - | - | 39.46M |
Short long term debt | - | - | - | - | - |
Short long term debt total | 651.72M | 558.39M | 390.03M | 327.29M | 338.45M |
Other stockholder equity | - | 317.38M | 298.29M | 244.98M | 162.73M |
Property plant equipment | - | 716.46M | 727.73M | 645.99M | 530.81M |
Total current assets | 179.64M | 224.05M | 82.80M | 127.90M | 59.25M |
Long term investments | 1815.39M | 1597.72M | 1378.55M | - | 947.80M |
Net tangible assets | - | 955.54M | 940.24M | 825.16M | 584.38M |
Short term investments | - | - | - | - | 66.13M |
Net receivables | 120.03M | 106.47M | 66.45M | 43.10M | 40.23M |
Long term debt | 640.52M | 553.59M | 380.14M | 327.29M | 325.45M |
Inventory | 0.00000M | - | - | - | -0.02700M |
Accounts payable | 14.97M | 9.79M | 2.04M | 9.30M | 5.86M |
Total permanent equity | - | - | - | - | - |
Noncontrolling interest in consolidated entity | - | - | - | - | - |
Temporary equity redeemable noncontrolling interests | - | - | - | - | - |
Accumulated other comprehensive income | 344.76M | 317.38M | 298.29M | - | 162.73M |
Additional paid in capital | - | - | - | - | - |
Common stock total equity | - | - | - | - | 588.39M |
Preferred stock total equity | - | - | - | - | - |
Retained earnings total equity | - | - | - | - | - |
Treasury stock | - | - | - | - | - |
Accumulated amortization | - | - | - | - | - |
Non currrent assets other | 1818.42M | - | - | - | 40.82M |
Deferred long term asset charges | - | - | - | - | - |
Non current assets total | 2602.71M | 2320.89M | 2114.89M | - | 1489.44M |
Capital lease obligations | 11.21M | 4.80M | 9.89M | - | 13.00M |
Long term debt total | - | - | - | 327.29M | 325.45M |
Breakdown | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 | 2019-05-31 |
---|---|---|---|---|---|
Type | yearly | yearly | yearly | yearly | yearly |
Date | 2023-05-31 | 2022-05-31 | 2021-05-31 | 2020-05-31 | 2019-05-31 |
Investments | -219.60100M | -218.82000M | - | -135.98300M | -153.77400M |
Change to liabilities | 11.33M | -1.75700M | 7.29M | 0.09M | 4.69M |
Total cashflows from investing activities | -219.60100M | -218.82000M | -122.62800M | -135.98300M | -153.77400M |
Net borrowings | 171.07M | 44.22M | -1.65600M | 54.31M | 96.68M |
Total cash from financing activities | 147.09M | 43.13M | 82.22M | 31.48M | 56.59M |
Change to operating activities | - | - | - | - | - |
Net income | 15.45M | 61.13M | 102.82M | -13.64200M | 45.37M |
Change in cash | -2.30600M | -70.16100M | 74.74M | -5.13800M | 7.43M |
Begin period cash flow | 9.74M | 79.91M | 17.62M | 22.76M | 10.86M |
End period cash flow | 7.44M | 9.74M | 79.91M | 17.62M | 18.29M |
Total cash from operating activities | 15.45M | 18.62M | 115.14M | 99.37M | 89.32M |
Issuance of capital stock | - | 20.00M | - | - | 1.30M |
Depreciation | 17.27M | 18.62M | 16.03M | 14.49M | 9.54M |
Other cashflows from investing activities | - | - | -66.00500M | -95.51600M | -80.87900M |
Dividends paid | -21.80600M | -19.41800M | 7.56M | -22.22700M | -12.73200M |
Change to inventory | - | - | - | - | - |
Change to account receivables | 5.64M | 13.11M | -2.72520M | -2.59500M | 0.29M |
Sale purchase of stock | - | - | - | 1.30M | 1.30M |
Other cashflows from financing activities | 223.19M | 158.02M | -4.56000M | 166.33M | 117.20M |
Change to netincome | 19.86M | 14.43M | -8.47920M | 101.02M | 29.42M |
Capital expenditures | 55.16M | 56.29M | 43.42M | 40.43M | 33.39M |
Change receivables | - | - | - | - | - |
Cash flows other operating | - | - | - | - | - |
Exchange rate changes | - | - | - | - | - |
Cash and cash equivalents changes | - | - | - | - | - |
Change in working capital | - | - | -56.24800M | -59.42400M | -44.91200M |
Stock based compensation | - | - | - | - | - |
Other non cash items | -15.44800M | -79.74900M | - | -0.85000M | -54.91500M |
Free cash flow | -39.71200M | -37.66900M | - | -40.43300M | -33.38900M |
Sector: Healthcare Industry: Medical Care Facilities
Company | Change (AUD) | Price (AUD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
---|---|---|---|---|---|---|---|---|
OCA Oceania Healthcare Ltd |
- -% | 0.73 | 18.25 | - | 1.99 | 0.57 | 4.55 | 19.09 |
RHCPA Ramsay Health Care Ltd Pref |
0.07 0.07% | 104.82 | 64.15 | - | 0.85 | - | ||
RHC Ramsay Health Care Ltd |
0.20 0.47% | 42.78 | 37.20 | 30.96 | 0.59 | 2.00 | 1.21 | 11.12 |
SNZ Summerset Group Holdings Ltd |
0.01 0.10% | 10.54 | 6.71 | - | 8.95 | 1.02 | 24.11 | 15.42 |
REG Regis Healthcare Ltd |
0.01 0.15% | 6.51 | - | 31.25 | 1.93 | 259.34 | 1.87 | 9.92 |
Oceania Healthcare Limited, together with its subsidiaries, owns and operates various care centers and retirement villages in New Zealand. The company operates through Care Operations, Village Operations, and Other segments. It also provides rest home, hospital, and dementia. In addition, the company offers independent living and rental properties for caring suites. Further, it provides accommodation, care, and related services to aged care residents; and support services, including administration, marketing, and operations. The company was formerly known as Retirement Care (NZ) Limited and changed its name to Oceania Healthcare Limited in September 2014. Oceania Healthcare Limited was incorporated in 2005 and is based in Auckland, New Zealand.
HSBC Tower, Auckland, New Zealand, 1010
Name | Title | Year Born |
---|---|---|
Mr. Brent Pattison BBS, C.A. | Chief Exec. Officer | NA |
Ms. Kathryn Waugh | Chief Financial Officer | NA |
Anita Hawthorne B.Com., C.A. | Group Gen. Mang. of Sales & Services | NA |
Dr. Frances Hughes | Gen. Mang. - Nursing & Clinical Strategy | NA |
Eli Parkin | Head of Devel. | NA |
Mr. Brent Pattison BBS, C.A. | Chief Executive Officer | NA |
Anita Hawthorne B.Com., C.A. | Group General Manager of Sales & Services | NA |
Eli Parkin | Head of Development | NA |
Mr. Brent Pattison BBS, C.A. | Chief Executive Officer | NA |
Anita Hawthorne B.Com., C.A. | Group General Manager of Sales & Services | NA |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.